Orthofix Medical Inc. (OFIX)
- Previous Close
13.10 - Open
13.12 - Bid 12.98 x 100
- Ask 13.04 x 100
- Day's Range
12.94 - 13.28 - 52 Week Range
9.57 - 21.60 - Volume
249,331 - Avg. Volume
358,206 - Market Cap (intraday)
485.912M - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
-- - EPS (TTM)
-4.12 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
18.47
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
www.orthofix.comRecent News: OFIX
Performance Overview: OFIX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OFIX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OFIX
Valuation Measures
Market Cap
490.03M
Enterprise Value
573.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.64
Price/Book (mrq)
0.82
Enterprise Value/Revenue
0.77
Enterprise Value/EBITDA
-7.22
Financial Highlights
Profitability and Income Statement
Profit Margin
-20.28%
Return on Assets (ttm)
-6.30%
Return on Equity (ttm)
-32.36%
Revenue (ttm)
746.64M
Net Income Avi to Common (ttm)
-151.4M
Diluted EPS (ttm)
-4.12
Balance Sheet and Cash Flow
Total Cash (mrq)
33.11M
Total Debt/Equity (mrq)
22.41%
Levered Free Cash Flow (ttm)
-118.37M
Research Analysis: OFIX
Company Insights: OFIX
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: OFIX
OFIX: Raising target price to $9.00
ORTHOFIX MEDICAL INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetOFIX: Lowering target price to $8.00
ORTHOFIX MEDICAL INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetOFIX: What does Argus have to say about OFIX?
ORTHOFIX MEDICAL INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetOFIX: Raising target price to $9.00
ORTHOFIX MEDICAL INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice Target